Sign inJoin waitlistJoin the waitlist

SL

Susan Lyons

Program Director · Henry Ford Health

Credentials: · · · ·

History

Henry Ford Health
Present

University of Michigan
1997–1999
Internal Medicine
1994–1997
University of Michigan Medical School
1990–1994

Research

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis
International journal of radiation oncology · 2006 · 260 citations
Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations
Journal of Biological Chemistry · 1992 · First of 4 authors · 201 citations
Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish
Cell Host & Microbe · 2007 · 189 citations

James Hayman
4 papers
DG
David Ginsburg
3 papers
Gregory Kalemkerian
3 papers
KC
Kemp Cease
3 papers
DB
Dean Brenner
2 papers
DA
Douglas Arenberg
2 papers
Jordan Shavit
2 papers
Kathleen Cooney
2 papers
Leonard Zon
2 papers
Marianne Juarez
2 papers
TL
Theodore Lawrence
2 papers
AL
Allen Lichter
1 paper

Grants

Myeloid Development in the Zebrafish
National Cancer Institute · K22
Contact PI · $477.9K · University of Michigan at Ann Arbor
2002–2005

Clinical trials

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Site PI · Recruiting · Phase 2, Phase 3
NRG Oncology
2022–2030
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2021–2027
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2020–2027
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2018–2027